Management Team
Wilson Zhang, M.D., Chief Executive Officer
Wilson Zhang, M.D., Chief Executive Officer
Wilson Zhang, M.D., Chief Executive Officer
Business management executive with 20 years’ experience working with diagnostics corporate business development sector, joint venture and international collaboration projects, and M&A activities.
Jack Davis, Chief Commercial Officer
Wilson Zhang, M.D., Chief Executive Officer
Wilson Zhang, M.D., Chief Executive Officer
25 years experience in the IVD, CRO, and global regulatory verticals with documented achievement in both the development and commercialization of novel assays in the personalized medicine and emerging disease markets.
John Christie, MBA, Chief Operating Officer
Wilson Zhang, M.D., Chief Executive Officer
John Christie, MBA, Chief Operating Officer
Business development executive with 20 years’ experience working with biotechnology and developing IP strategy on an international scale.
Bo Ning, Ph.D., Chief Technology Officer
Yuanyuan Kang, Ph.D., Senior Director Research and Development
John Christie, MBA, Chief Operating Officer
Contributed the key design for CRISPR detection of TB and published a series of papers in leading peer-reviewed journals including Nature Nanotechnology, Lancet Microbe, Science Advances, JCI, Biosensor & Bioelectronics and Cell Reports Methods.
Yuanyuan Kang, Ph.D., Senior Director Research and Development
Yuanyuan Kang, Ph.D., Senior Director Research and Development
Yuanyuan Kang, Ph.D., Senior Director Research and Development
15+ years research in academia and industry. Experienced in the development, qualification, and validation of CLIA, cGMP, and cGLP-qualified molecular biomarker assays for preclinical and clinical trials in phases I, II, and III.
Advisory Team
Tony Hu, Ph.D., Chief Science Advisor
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Weatherhead Presidential Chair in Biotechnology Innovation
Director, Center for Intelligent Molecular Diagnostics
Professor of Biochemistry and Molecular Biology, Microbiology, and Biomedical Engineering
School of Medicine, Tulane University
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Dr. Zhen Zhao, PhD, DABCC, FADLM, Advisory Member
Dr. Zhen Zhao is a Professor of Clinical Pathology and Laboratory Medicine at Weill Cornell Medicine and Director of the Central Laboratory at NewYork-Presbyterian/Weill Cornell. She serves as Chair of the IFCC Task Force on Outcome Studies in Laboratory Medicine and is President-Elect of the ADLM Academy. She is also the Past President o
Dr. Zhen Zhao is a Professor of Clinical Pathology and Laboratory Medicine at Weill Cornell Medicine and Director of the Central Laboratory at NewYork-Presbyterian/Weill Cornell. She serves as Chair of the IFCC Task Force on Outcome Studies in Laboratory Medicine and is President-Elect of the ADLM Academy. She is also the Past President of the NACCCA. A leader in laboratory diagnostics,
Dr. Zhao has published over 100 peer-reviewed papers and received the IFCC Distinguished Women Scientist Award for her contributions to in vitro diagnostics.